Key result
Only ~40% of hypertensive outpatients adhere to antihypertensive pharmacotherapy.
Cross-Sectional (n=156)
No
Adherence to antihypertensive pharmacotherapy is low (39.7%) among outpatients in this Colombian cohort, highlighting a significant gap in chronic disease management.
No takes yet. Share an insight, caveat, or question.
Low adherence in this outpatient cohort signals need for targeted support; leaves open whether interventions improve control or outcomes in similar settings.
Carlos Julio Ramírez Pinzón (2014) conducted a cross-sectional in Hypertension (n=156). Antihypertensive pharmacotherapy was evaluated on Adherence to pharmacological treatment measured by the Morisky-Green test. Only 39.74% of hypertensive outpatients were adherent to their pharmacological treatment according to the Morisky-Green test.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: